November 15, 2013 | Lucid, Strategic planning
The benefits of including medical experts in your brand planning team
Everyone who works in pharma knows that a significant part of their year is dedicated to strategic planning. As soon as the latest five-year rolling plan is signed off, work begins on the next five years. Templates are completed and everyone loves spending days in whacky meetings talking about the great new insights you have gathered since the last planning cycle. A huge amount of time and energy is focussed on engaging the internal team. Is this one of the best opportunities you have to engage your external experts or KOLs? Could this deliver a better plan and are there other upsides of this engagement?
Why not select a team of experts and run a parallel planning process?
Immediately, I can hear anybody who has read this far mutter “we don’t have time to do this”. Lack of time is the most commonly cited reason for physicians not changing their clinical practice – even when the change will save time in the long-term because patient outcomes are better. We propose that by investing time in engaging experts in your planning, the resulting group of engaged experts will save you enormous amounts of time briefing and planning individual activities once implementation begins. (I know, you don’t actually care about this, you’ve got a new job by now!)
How might this work in practice?
Using the standard planning process, there are a number of opportunities to engage your experts. The most efficient way to do this is probably in an advisory board setting, but smaller focus groups or even structured 1:1 meetings would work.
At an advisory board or similar, you could run the following sessions:
If this can’t be done as an advisory board, consider smaller groups, covering parts of the above. You may already do some of this with a select few of your experts, but to really influence your plan, you need to do all of it with a range of experts.
Which experts should we include?
While the temptation will be to include experts that you know and that are close to your brand, if you are to see the value of this approach in delivering a better plan, you need to include a broad range of experts. For any brand, you are likely to be running some disease awareness and some differentiation activities. You need to have assessed your group of experts in terms of their ‘progressive disease management’ and their ‘brand loyalty’. Once you have done this, you can select experts from across the spectrum.
Generating true engagement
None of the above is really rocket science, nor is it too time consuming. However, the key to using this as a tool to develop better engagement of experts in your plans is to make sure you keep the dialogue open. Following the advisory board, it is critical that the advisors are contacted regularly to keep them informed about what you are doing with the information and ideas they provided and also how the actual plans are evolving. This can be done through bi-monthly webinars or, at the simplest level, via email.
I am happy with my planning process, why would I do this?
The benefits of this approach are two-fold. You can leverage the clinical insights generated by running these sessions to build a more robust and relevant plan. If you ask them for their views of the big ticket changes in the environment over the plan period you are likely to be able to sift out the really big things that will affect your plan. And if this is done in an advisory setting, you will be able to hear and assess the impact on the group as a whole, rather than get many individual viewpoints, which could be misleading.
But more important than delivering a more insightful plan is the real and lasting engagement you will have generated with this group of experts. When it comes to implementation, they will be aligned with your thinking. This will save hours in discussion as you try to agree what’s important to each of you at a later date.
This content was provided by Lucid Group Communications Limited
Company Details
Latest Content from Lucid Group Communications Limited
Lucid Group launch their new branding in this month's PME magazine.
In their day-to-day, everybody at Lucid Group strives to develop outstanding medical education programmes to improve patient outcomes. Over the summer, however, they like to take some time to turn...
On 13 July, Lord Lieutenant Sir Henry presented Lucid Group with the Queen’s Award for Enterprise in International Trade. This award recognises UK-based businesses that have achieved outstanding growth overseas...
Lucid Group’s commitment to improving patient outcomes across the globe was recognised at the 2017 Communiqué Awards in London last night. The agency won the awards for Excellence in Communications...
The past year has been the most successful for Lucid Group yet. They have celebrated their 10th year of business, launched their new Strategic Consultancy, won a Queen’s Award for...
The days when medical communication simply aimed to raise awareness of clinical challenges are well and truly over. In recent years, we have seen a clear shift towards changing physicians’...
Lucid Group is thrilled to learn that all its entries for the 2017 Communiqué Awards have been shortlisted as finalists! The categories include: Communications Consultancy of the Year Lucid Group Excellence in Communications via...
When working in medical communications, one of the most common questions we get asked is “What is it that you actually do?” Many students and graduates are unaware of medical...
At times, it feels like procedures are designed to frustrate, and templates often hinder rather than help. Especially in strategic planning, where a certain degree of creativity and innovation is...
No team members were getting their hands dirty today! Instead, they were treated to car valets and manicures as a thank you for all their hard work delivering a number...
